The week - A scientist's attempt to catalog species by DNA barcoding turns up surprises -- and criticism; and vote for your favorite laboratory Web site.
The week - The value of race-based clinical trials; neurogenesis, the brain-machine interface and highlights from The Scientist's November issue that focused on neuroscience
The week - American Chemical Society compensation causes complaints; sex-linked genes play a role in addiction; scientist uncovers new heart anatomy in Drosophila; and Panama's ecology faces big changes ahead
The week - Satiety and reward are linked by the hormone pyy; the extensive misconduct of a Norwegian researcher continues to surface; big pharma sues US patent office; and what it takes to be the best place to do a postdoc
The week - Author Dan Greenberg discusses capitalism in academic science; salmonella in space become deadlier; Congress gets concerned about biosafety; and researchers develop hair cells on demand
The week - How the accidental discovery of lysophospholipid receptor happened and has since affected lipidology; Univ New Hampshire offers to reinstate banned professor
The week - NIH considers science in space; what makes an institution one of the Best Places to Work; and why even the best institutions find room for improvement
The week - Hookworm vaccine clinical trials start in rural Brazil; FDA accused of violating First Amendment rights; and hunger protein links stress and obesity
The week - The roots of Philadelphia's cloning contributions run deep; results from The Scientist's online experiment about stem cell nuclear transfer; Congress begins the budget process; a software bug causes retraction; deCODE settles lawsuit
The week - Careers editor Edyta Zielinska and executives from Amgen talk perks; and whether federal regulations on dietary supplements violate free speech
The week - Feature writer Andrew Holtz talks about the passionate pursuit of oncolytic viruses; Chickens in the city grab attention; and debate reignites over the value of case reports
The week - Feature writer Ishani Ganguli discusses whether fMRI can become the next lie detector; Tanner Edis talks about his new book "An Illusion of Harmony: Science and Religion in Islam"
The week - Katherine Eban discusses the US government's disappointing bioterror surveillance initiative; author and geneticist Bryan Sykes talks about his latest book on the surprising history of English genes; and another high-profile research paper is retracted
The week - Philip Mackowiak's book diagnoses the death of Edgar Allen Poe and other famous people; scientists boycott Reed Elsevier; and The Scientist announces winners of the Life Science Industry Awards
The week - Dan Zimmerman explains his funding solution to the vaccine conundrum; author Linda Lear describes the scientific life of Beatrix Potter; and a plagiarism blame game in the news
The week - The Scientist's editors give PR a piece of their minds; and evolutionary biology and religion shake hands in David Sloan Wilson's latest book
The week - An ecologist describes what might be a unifying theory in biology; why we need your help with a new online stem cell feature; and Governor Spitzer and CIRM are in the news.
The week - Scientists tell us how they would build the perfect body parts, from reshaping the eye to self-powered ankles; and Wayne Grody tells us about his life as a scientific advisor in Hollywood.
The week - Staff writer Andrea Gawrylewski talks with Pritpal S. Tamber about trends in publication retractions and why scientific misconduct is hard to track; and editor Edyta Zielinska hears from two post-docs about industry life.
The week - Editor-in-chief Richard Gallagher and deputy editor Ivan Oransky give a behind-the-scenes look at the March issue, from a decade-old publishing controversy to retraction vocabulary; and senior editor Brendan Maher checks in from a Keystone conference on reproduction.
The week - Senior editor Brendan Maher talks with Don Brown about the early days at the Carnegie Institution; contributor Ishani Ganguli gives an update on a tenure-or-bust hunger strike; and Andrea Gawrylewski has the latest from The Scientist Daily News.
The week - Staff writer Kerry Grens hears from Steve Rawsthorne about the celebrities who sell bad science; contributor David Kirby reads an essay on Hollywood's take on heredity; and intern Andrea Gawrylewski has the perfect Valentine's gift for the scientist in your life.
The week - Staff writer Kerry Grens talks with deputy editor Ivan Oransky about his visits to various dairy farms, what he learned about the risks of drinking milk, and how a cow reacts to having a farmer's arm reach into her stomach.
The week - Staff writer Kerry Grens speaks with Carl Cohen about what happens when lab researchers fight, and how lab leaders can smooth over tensions; and intern Andrea Gawrylewski has the news on the recent identification of the Vitamin A receptor and evidence of the p53 gene's tumor suppressing power.
The week - Contributor Ted Agres interviews Dave Moore of the Association of American Medical Colleges about issues facing the new democrat-led Congress; and from our culture Friday series, staff writer Kerry Grens features a book review of The Fourth Horseman.
The week - Staff writer Kerry Grens talks with Indoor Technologies president Martin Chapman about the uncertain existence of the lauded hypoallergenic cat; and intern Andrea Gawrylewski has updates on a new gene implicated in Alzheimer's disease and the status of a vaccine against Chikungunya virus.
The week - Feature contributor Kate Travis talks with Robert Seder about the promise of developing vaccines based on Toll-like receptors, and Bruce Beutler tells intern Andrea Gawrylewski why TLRs might not be the answer.
The week - Feature contributor Brendan Borrell talks with former Evolution editor Richard Palmer about fraud accusations against star ornithologist Anders Pape Møller; deputy editor Ivan Oransky points out a potentially overlooked conflict of interest by NIH researcher Thomas Walsh.
The week - Alex Rich looks back 50 years at the discovery of the RNA double helix; researchers report a new class of small, non-coding RNAs; and MHC-matched embryonic stem cells graft in mice successfully.
The week - Feature contributor Merrill Goozner talks about his time in Asia visiting malaria clinics to understand why less effective drugs are often used instead of artemisinin; a lead researcher at the NIH pleads guilty to consulting for Pfizer; and lifespan?s link to telomerase expression takes a blow.
The week - Feature writer Alan Dove interviews Gerd Maul on the challenges to developing a vaccine for cytomegalovirus; and staff writer Kerry Grens has news of viral defenses against RNA silencing and troubles in ensuring drug safety
The week - Staff writer Kerry Grens speaks with John Radford about what to expect for an annual bonus this year, and wraps up the news with a look at structural variations in the human genome.
The week - Juhi Yahjnik reports on the challenges of becoming a scientist in high school; and staff writer Kerry Grens rounds up the news with colon cancer stem cells, animal terrorism legislation, and avian flu mutants.
The week - Juhi Yajnik asks Polydex Pharmaceuticals CEO George Usher how to be successful in getting non-profit funding; and staff writer Kerry Grens rounds up the news with upcoming legislation and an investigation into possible scientific misconduct.
The week - feature contributor Gail Dutton talks with Steven Deeks about patients who are resistant to HIV; and staff writer Kerry Grens rounds up the news with cool mice living longer, EPA libraries shutting down, and the NIH rethinking plans for an anti-terror lab
The week - staff writer Kerry Grens rounds up the news with a controversial publication about cancer among IBM employees, and Brigham Young University's fight with Pfizer over Celebrex; and senior editor Brendan Maher and feature contributors Lance Liotta and Emanuel Petricoin discuss the merits of clinical proteomics
The week - how objective are scientists when it comes to politics? Three-thousand responses to our online poll indicate that party affiliation strongly colors their opinions. Daniel Sarewitz director of the Consortium for Science, Policy, and Outcomes at Arizona State University, discusses the results with staff writer Kerry Grens. Also, a new mutation is linked to brittle bone disease, and a preview of what's to come in our November print edition.
The week - staff writer Kerry Grens rounds up the news with testimony on a lawsuit between deCODE Genetics and former employees, a discovery into the genetics behind XX males, and plans for change by the new editor-in-chief at PNAS; and senior editor Brendan Maher and behavioral ecologist William Brown discuss what makes a dancer sexy as they reveal the results of our online dancing survey;
The week - senior editor Brendan Maher talks with Nobel laureate Paul Greengard and Per Svenningsson about how antidepressants, neuro-psychiatric disorders, and drugs of abuse and addiction appear to act in the brain through a single regulator, DARPP32. Also, Staff writer Kerry Grens reports on scientists in the UK that have found evidence supporting the evolutionary theory of punctuated equilibrium.
The week - staff writer Kerry Grens talks about a survey of congressional candidates' stances on research funding, in preparation for the midterm elections; editorial intern Juhi Yajnik reports on the financial rewards of winning the Nobel prize; and news editor Alison McCook speaks with L A Times reporter Joe Mathews, author of The People's Machine: Governor Schwarzenegger and the Rise of Blockbuster Democracy, about the struggle over voter-approved stem cell research funding in California.
The week - A look at how married researchers working in the same company manage their relationship without coming to blows. Plus, Kate Travis investigates a new report that finds industry scaling back dollars for academic R&D.
The Week - the Lasker Foundation announced the 2006 award recipients for its prizes in biomedical research.
The Scientist's Kerry Grens has a run-down of the winners; Juhi Yajnik chats with Joseph Gall, winner of the Lasker Award for Special Achievement in Medical Science. Also this week, animal rights activists are sent to prison, and two studies find RNA interference screens are less faithful than previously thought.
The Week - a look at why what your grandmother ate when she was pregnant with your mother may affect your children's health. At its core, the field of nutrigenomics is the study of how genes and nutrients interact to promote health or disease. In the September issue of The Scientist, Kate Travis takes a look at the state of the field, the early findings that will fuel further research, and the challenges that lie ahead. She recently spoke with Patrick Stover, one of the pioneers in nutrigenomics research.
The Week - Senior editor Brendan Maher speaks to Gordana Vunjak-Novakovic, author of a feature in our September issue. Tissue engineering's most formidable challenge, says Vunjak-Novakovic, is mimicking the environment in which tissues grow naturally. Here she tells us how the work toward overcoming that challenge could change the face of transplant medicine and also how it is growing new and exciting collaborations.
The Week - Chandra Shekhar reports on the challenges facing the new director of the NASA Astrobiology Institute. Andrew Holtz finds out why there?s stiff resistance to financial disclosure at the institute in charge of handing out California?s stem cell research windfall. Finally, senior editor Brendan Maher reveals the truth behind a headline-grabbing Nature study claiming that embryonic stem cell lines could be created without destroying embryos.
The Week - Stephen Pincock writes about an unusual occurrence: An editor who is warning readers about a study, but not retracting it. Chandra Shekhar reports on how scientists reversed evolution for a 500 million-year-old gene. F
